Kingsview Wealth Management, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1791965
GRANTS PASS, OR
Position in GILD
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$2,254,537
+$64,895 QoQ
Shares Held
17,845
+13.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#797
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Jun 30, 2026CallValue
$12,634
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kingsview Wealth Management, LLC holds $172,226,536 across 14 Drug Manufacturers - General names. GILD ranks #8 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
82,083 | $98,452,820 | |
| 2 | JNJ |
Johnson & Johnson
|
94,143 | $23,909,497 | |
| 3 | ABBV |
AbbVie Inc.
|
71,689 | $18,039,819 | |
| 4 | MRK |
Merck & Co., Inc.
|
80,440 | $10,336,540 | |
| 5 | AMGN |
Amgen Inc
|
18,729 | $6,782,145 | |
| 6 | PFE |
Pfizer Inc
|
212,065 | $5,106,525 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
45,093 | $2,598,258 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
17,845 | $2,254,537 |
All Filings in GILD
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,634 | 100 | Call | Sole | 2026-08-19 | |
| 2026-06-30 | $2,254,537 | 17,845 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $2,189,642 | 15,711 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,020,668 | 16,463 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,832,943 | 16,513 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,587,689 | 41,379 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $4,846,274 | 43,251 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $3,880,832 | 42,014 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $1,670,344 | 19,923 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,255,219 | 18,295 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,342,086 | 18,322 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,517,155 | 18,728 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,541,440 | 20,569 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $3,019,679 | 39,181 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,871,546 | 46,662 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,894,261 | 33,713 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,364,952 | 22,126 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,161,039 | 18,784 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $1,364,793 | 22,957 | Shares | Sole | 2024-02-08 | |
| 2021-12-31 | $1,305,455 | 17,979 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $1,182,770 | 16,933 | Shares | Sole | 2021-12-03 | |
| 2021-06-30 | $3,000 | 2,000 | Call | Sole | 2021-08-17 | |
| 2021-06-30 | $1,096,182 | 15,919 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $890,730 | 13,782 | Shares | Sole | 2021-05-24 | |
| 2021-03-31 | $6,463 | 100 | Put | Sole | 2021-05-24 | |
| 2020-12-31 | $762,448 | 13,087 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,046,110 | 16,555 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $15,388 | 200 | Put | Sole | 2020-08-14 | |
| 2020-06-30 | $1,101,242 | 14,313 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $934,051 | 12,494 | Shares | Sole | 2020-05-11 | |
| 2020-03-31 | $8,476 | 5,100 | Call | Sole | 2020-05-11 | |
| 2020-03-31 | $7,476 | 100 | Put | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||